Wednesday, March 09, 2022

Cancer cells become more aggressive when migrating through small spaces

The findings of new research suggest that squeezing through tight spaces makes cancer cells more aggressive and helps them evade cell death.
 
The findings, published in 'eLife', reveal how mechanical stress makes cancer cells more likely to spread, or metastasis.
 
While metastasis is the cause of most cancer deaths, there are currently no available cures. However, the new results may help scientists develop novel approaches to treat or prevent metastasis. It can be a tight squeeze for cancer cells to escape their tumour or enter tiny blood vessels, called capillaries, to spread through the body. The cells must collapse and change their shape to do this, in a process called confined migration. As they spread, the cells must also avoid detection and destruction by the immune system.
 
"Mechanical stress can cause cancer cell mutations, as well as an uncontrolled increase in cell numbers and greater tissue invasion," explains first author Deborah Fanfone, Postdoctoral Fellow at the Cancer Research Center of Lyon, France. "We wanted to know if the mechanical stress of confined migration makes cancer cells more likely to metastasise, and how this happens."
 
To answer these questions, Fanfone and colleagues forced human breast cancer cells through a membrane with tiny, three-micrometer-sized holes to simulate a confined migration environment. After just one passage through the membrane, they found that the cells became more mobile and resistant to anoikis - a form of programmed cell death that occurs when cells become detached from the surrounding network of proteins and other molecules that support them (the extracellular matrix).
The cells were also able to escape destruction by immune natural killer cells.
 
Further experiments showed that increased expression of inhibitory-of-apoptosis proteins (IAPs) increased the resistance of cancer cells to anoikis. Treating the cancer cells with a new type of cancer drug called a SMAC mimetic, which degrades IAPs, removed this protection.
 
The team then studied how breast cancer cells that had undergone confined migration behave when administered to immune-suppressed mice. They found these mice developed more lung metastases than mice that were administered with breast cancer cells that had not been exposed to confined migration.
 
"By mimicking confined migration, we've been able to explore its multifaceted effects on cancer aggressiveness," says senior author Gabriel Ichim, who leads the Cancer Cell Death team at the Cancer Research Center of Lyon. "We've shown how the process boosts survival in cancer cells and makes them more prone to forming deadly metastases."
 
The authors add that these results may lead to additional studies of potential metastasis treatments, such as therapies that soften tumours to reduce mechanical stress on cancer cells, or that block IAPs. These include SMAC mimetics, which are currently being tested in clinical trials as a possible new treatment approach.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

Labels: , , , , , , , , , ,

Tuesday, January 07, 2020

New combination of antibodies leads to more effective tumor destruction

The simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demonstrated by a study in animal models by medical oncologists and scientists at the University of Basel that has been published in the scientific journal PNAS. Patients who do not respond to current immunotherapy options could benefit most from this new treatment.

In recent years, immunotherapies against cancer have raised great hopes. These novel therapies recruit the body's immune system to destroy cancerous tissue. An antibody that activates the CD40 receptor on the surface of immune cells and thus stimulates the production of natural killer T-cells showed a promising effect in preclinical studies.

However, in subsequent clinical trials, the success of the CD40 antibody fell far short of expectations - less than 20% of patients responded. The research group Cancer Immunology at the University of Basel has now shown in animal models that the effect of the anti-CD40 antibody can be increased significantly by combining it with two other antibodies that attach to tumor blood vessels.

Open the way to the tumor

The starting point for the study was the observation that the administration of anti-CD40 antibodies leads to an increase in killer T-cells as intended - but these can then only be detected in the peripheral areas and not in the interior of the tumor. The researchers suspected that this was due to the nature of the tumor's blood vessels.
Normally, the blood vessels of a tumor are leaky or stunted. Therefore, there is no good way for killer T-cells to get inside. Our hypothesis was that the killer cells are able to invade the tumor and destroy it only if there are enough healthy blood vessels."
Dr. Abhishek Kashyap, study leader
Therefore, they combined the anti-CD40 antibody with two other anti-angiogenic antibodies that are able to stabilize the tumor blood vessels. One of the anti-angiogenetic antibodies is already approved for cancer therapy under the name Avastin, while the other is still in clinical development. All antibodies were provided by Roche.

New combination destroys tumor tissue

The researchers then tested this new combination of antibodies in several animal models for different types of cancer, such as colorectal, breast and skin cancer. As expected, the combination of the three antibodies significantly improved tumor tissue destruction in all cancers.

A more detailed analysis also showed that this success was based on the predicted mechanism: the addition of the two anti-angiogenetic antibodies ensured the tumors had more intact blood vessels. Unexpectedly, however, the investigations also showed that the antibody combination very effectively strengthens the immune system in several ways; for example, through a better penetration of the tumor by killer cells and by promoting a tumor-hostile inflammatory reaction in the tumor microenvironment.

"Our results illustrate how important it is to understand the biology of tumors," says Kashyap. He believes that patients with 'cold' tumors - tumors that do not respond well to immunotherapy - could benefit most from this new combination. "The anti-angiogenetic antibodies may make the 'cold' tumors 'hot', so that immunotherapy functions better." In the meantime, several early clinical trials of similar therapies in humans are underway.

Cooperation strengthens results

According to Kashyap, the strength of the study lies not only in the large effects measured, but also in the fact that several different laboratories achieved the same results. The experiments were carried out at the University Hospital of Basel, EPFL and the Roche Innovation Center Zurich.

This is also confirmed by Alfred Zippelius, Professor of Translational Oncology at the University of Basel and senior author of the study: "The innovative and translational potential of this work is the result of a close and excellent collaboration between applied and basic research, between the University of Basel and EPFL, and between academia and industry."

this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , ,

Thursday, August 15, 2019

Air pollution as bad as smoking a cigarette pack per day

Researchers have found that ozone air pollution which is increasing with climate change can accelerate lung disease as much as that by smoking a pack of cigarettes a day.

“We were surprised to see how strong air pollution’s impact was on the progression of emphysema on lung scans, in the same league as the effects of cigarette smoking, which is by far the best-known cause of emphysema,” said a Prof.

If you live in areas with increased levels of ozone, researchers found an increase in emphysema roughly the equivalent of smoking a pack of cigarettes a day for 29 years.

The study,  demonstrates an association between long-term exposure to major air pollutants – especially ozone – with an increase in emphysema seen on lung scans.


Emphysema is a condition in which destruction of lung tissue leads to wheezing, coughing and shortness of breath and increases the risk of death.

The results are based on an extensive, 18-year study involving more than 7,000 people and a detailed examination of the air pollution they encountered between 2000 and 2018 in six metropolitan regions across the US. The participants were drawn from the Multi-Ethnic Study of Atherosclerosis (MESA) Air and Lung studies.

“To our knowledge, this is the first longitudinal study to assess the association between long-term exposure to air pollutants and progression of percent emphysema in a large, community-based, multi-ethnic cohort,” said an Assistant Prof.

While most of the airborne pollutants are in decline because of successful efforts to reduce them, ozone has been increasing, researchers said. Ground-level ozone is mostly produced when ultraviolet light reacts with pollutants from fossil fuels.

 
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/                                                                                                                                                FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                                       https:// kneereplacement-stickclub.blogspot.com/                                                                                                                     FOR CROCHET DESIGNS                                                                                                   
                                https://gscrochetdesigns.blogspot.com

 

Labels: , , , , , , , , , , , , , ,